APO Research
Talk to an analyst

APO RESEARCH · REPORT

Filgrastim Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Filgrastim Injection Industry Growth and Trends Forecast to 2032

2 January 202695 pages

Choose your research edition.

Industry ResearchFilgrastim Injection Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Filgrastim Injection Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Filgrastim Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Filgrastim Injection Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Filgrastim Injection Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Filgrastim Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Filgrastim Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Filgrastim Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Filgrastim Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Filgrastim Injection include Teva Pharmaceuticals, Novartis AG, Pfizer, Amgen Inc and Accord Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Filgrastim Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Filgrastim Injection market size, estimates, and forecasts are presented in terms of sales volume (K L) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Filgrastim Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Filgrastim Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Filgrastim Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Filgrastim Injection Market by Company

Teva Pharmaceuticals

Novartis AG

Pfizer

Amgen Inc

Accord Healthcare

Filgrastim Injection Segment by Type

300mcg/0.5mL (Prefilled Syringe)

300mcg/mL (vial)

480mcg/0.8mL (Prefilled Syringe)

480mcg/1.6 mL (vial)

Filgrastim Injection Segment by Application

Adult Use

Pediatric Use

Geriatric Use

Filgrastim Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Filgrastim Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Filgrastim Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Filgrastim Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Filgrastim Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Filgrastim Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 300mcg/0.5mL (Prefilled Syringe) Table 2. Major Company of 300mcg/mL (vial) Table 3. Major Company of 480mcg/0.8mL (Prefilled Syringe) Table 4. Major Company of 480mcg/1.6 mL (vial) Table 5. Global Filgrastim Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Filgrastim Injection Sales by Type (2021-2026) & (K L) Table 7. Global Filgrastim Injection Sales Market Share in Volume by Type (2021-2026) Table 8. Global Filgrastim Injection Sales by Type (2021-2026) & (US$ Million) Table 9. Global Filgrastim Injection Sales Market Share in Value by Type (2021-2026) Table 10. Global Filgrastim Injection Price by Type (2021-2026) & (US$/L) Table 11. Global Filgrastim Injection Sales by Type (2027-2032) & (K L) Table 12. Global Filgrastim Injection Sales Market Share in Volume by Type (2027-2032) Table 13. Global Filgrastim Injection Sales by Type (2027-2032) & (US$ Million) Table 14. Global Filgrastim Injection Sales Market Share in Value by Type (2027-2032) Table 15. Global Filgrastim Injection Price by Type (2027-2032) & (US$/L) Table 16. North America Filgrastim Injection Sales by Type (2021-2026) & (K L) Table 17. North America Filgrastim Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Filgrastim Injection Sales by Type (2021-2026) & (K L) Table 19. Europe Filgrastim Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Filgrastim Injection Sales by Type (2021-2026) & (K L) Table 21. Asia-Pacific Filgrastim Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Filgrastim Injection Sales by Type (2021-2026) & (K L) Table 23. Latin America Filgrastim Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Filgrastim Injection Sales by Type (2021-2026) & (K L) Table 25. Middle East and Africa Filgrastim Injection Sales by Type (2021-2026) & (US$ Million) Table 26. Filgrastim Injection Industry Trends Table 27. Filgrastim Injection Industry Drivers Table 28. Filgrastim Injection Industry Opportunities and Challenges Table 29. Filgrastim Injection Industry Restraints Table 30. Global Filgrastim Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Filgrastim Injection Revenue Market Share by Company (2021-2026) Table 32. Global Filgrastim Injection Sales by Company (2021-2026) & (K L) Table 33. Global Filgrastim Injection Sales Share by Company (2021-2026) Table 34. Global Filgrastim Injection Market Price by Company (2021-2026) & (US$/L) Table 35. Global Filgrastim Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Filgrastim Injection Major Company Production Sites and Headquarters Table 37. Global Filgrastim Injection Company, Product Type & Application Table 38. Global Filgrastim Injection Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Filgrastim Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Filgrastim Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Filgrastim Injection Sales by Region (2021-2026) & (K L) Table 43. Global Filgrastim Injection Sales Market Share in Volume by Region (2021-2026) Table 44. Global Filgrastim Injection Sales by Region (2021-2026) & (US$ Million) Table 45. Global Filgrastim Injection Sales Market Share in Value by Region (2021-2026) Table 46. Global Filgrastim Injection Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 47. Global Filgrastim Injection Sales by Region (2027-2032) & (K L) Table 48. Global Filgrastim Injection Sales Market Share in Volume by Region (2027-2032) Table 49. Global Filgrastim Injection Sales by Region (2027-2032) & (US$ Million) Table 50. Global Filgrastim Injection Sales Market Share in Value by Region (2027-2032) Table 51. Global Filgrastim Injection Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2027-2032) Table 52. Global Filgrastim Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Filgrastim Injection Sales by Application (2021-2026) & (K L) Table 54. Global Filgrastim Injection Sales Market Share in Volume by Application (2021-2026) Table 55. Global Filgrastim Injection Sales by Application (2021-2026) & (US$ Million) Table 56. Global Filgrastim Injection Sales Market Share in Value by Application (2021-2026) Table 57. Global Filgrastim Injection Price by Application (2021-2026) & (US$/L) Table 58. Global Filgrastim Injection Sales by Application (2027-2032) & (K L) Table 59. Global Filgrastim Injection Sales Market Share in Volume by Application (2027-2032) Table 60. Global Filgrastim Injection Sales by Application (2027-2032) & (US$ Million) Table 61. Global Filgrastim Injection Sales Market Share in Value by Application (2027-2032) Table 62. Global Filgrastim Injection Price by Application (2027-2032) & (US$/L) Table 63. North America Filgrastim Injection Sales by Application (2021-2026) & (K L) Table 64. North America Filgrastim Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Filgrastim Injection Sales by Application (2021-2026) & (K L) Table 66. Europe Filgrastim Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Filgrastim Injection Sales by Application (2021-2026) & (K L) Table 68. Asia-Pacific Filgrastim Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Filgrastim Injection Sales by Application (2021-2026) & (K L) Table 70. Latin America Filgrastim Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Filgrastim Injection Sales by Application (2021-2026) & (K L) Table 72. Middle East and Africa Filgrastim Injection Sales by Application (2021-2026) & (US$ Million) Table 73. Teva Pharmaceuticals Company Information Table 74. Teva Pharmaceuticals Business Overview Table 75. Teva Pharmaceuticals Filgrastim Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 76. Teva Pharmaceuticals Filgrastim Injection Product Portfolio Table 77. Teva Pharmaceuticals Recent Development Table 78. Novartis AG Company Information Table 79. Novartis AG Business Overview Table 80. Novartis AG Filgrastim Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 81. Novartis AG Filgrastim Injection Product Portfolio Table 82. Novartis AG Recent Development Table 83. Pfizer Company Information Table 84. Pfizer Business Overview Table 85. Pfizer Filgrastim Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 86. Pfizer Filgrastim Injection Product Portfolio Table 87. Pfizer Recent Development Table 88. Amgen Inc Company Information Table 89. Amgen Inc Business Overview Table 90. Amgen Inc Filgrastim Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 91. Amgen Inc Filgrastim Injection Product Portfolio Table 92. Amgen Inc Recent Development Table 93. Accord Healthcare Company Information Table 94. Accord Healthcare Business Overview Table 95. Accord Healthcare Filgrastim Injection Sales (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 96. Accord Healthcare Filgrastim Injection Product Portfolio Table 97. Accord Healthcare Recent Development Table 98. North America Filgrastim Injection Market Size Growth Rate (CAGR) by Country (K L): 2021 VS 2025 VS 2032 Table 99. North America Filgrastim Injection Sales by Country (2021-2026) & (K L) Table 100. North America Filgrastim Injection Sales Market Share by Country (2021-2026) Table 101. North America Filgrastim Injection Sales Forecast by Country (2027-2032) & (K L) Table 102. North America Filgrastim Injection Sales Market Share Forecast by Country (2027-2032) Table 103. North America Filgrastim Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. North America Filgrastim Injection Market Size by Country (2021-2026) & (US$ Million) Table 105. North America Filgrastim Injection Market Share by Country (2021-2026) Table 106. North America Filgrastim Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. North America Filgrastim Injection Market Share Forecast by Country (2027-2032) Table 108. Europe Filgrastim Injection Market Size Growth Rate (CAGR) by Country (K L): 2021 VS 2025 VS 2032 Table 109. Europe Filgrastim Injection Sales by Country (2021-2026) & (K L) Table 110. Europe Filgrastim Injection Sales Market Share by Country (2021-2026) Table 111. Europe Filgrastim Injection Sales Forecast by Country (2027-2032) & (K L) Table 112. Europe Filgrastim Injection Sales Market Share Forecast by Country (2027-2032) Table 113. Europe Filgrastim Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Europe Filgrastim Injection Market Size by Country (2021-2026) & (US$ Million) Table 115. Europe Filgrastim Injection Market Share by Country (2021-2026) Table 116. Europe Filgrastim Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Europe Filgrastim Injection Market Share Forecast by Country (2027-2032) Table 118. Asia-Pacific Filgrastim Injection Market Size Growth Rate (CAGR) by Country (K L): 2021 VS 2025 VS 2032 Table 119. Asia-Pacific Filgrastim Injection Sales by Country (2021-2026) & (K L) Table 120. Asia-Pacific Filgrastim Injection Sales Market Share by Country (2021-2026) Table 121. Asia-Pacific Filgrastim Injection Sales Forecast by Country (2027-2032) & (K L) Table 122. Asia-Pacific Filgrastim Injection Sales Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Filgrastim Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Filgrastim Injection Market Size by Country (2021-2026) & (US$ Million) Table 125. Asia-Pacific Filgrastim Injection Market Share by Country (2021-2026) Table 126. Asia-Pacific Filgrastim Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Asia-Pacific Filgrastim Injection Market Share Forecast by Country (2027-2032) Table 128. Latin America Filgrastim Injection Market Size Growth Rate (CAGR) by Country (K L): 2021 VS 2025 VS 2032 Table 129. Latin America Filgrastim Injection Sales by Country (2021-2026) & (K L) Table 130. Latin America Filgrastim Injection Sales Market Share by Country (2021-2026) Table 131. Latin America Filgrastim Injection Sales Forecast by Country (2027-2032) & (K L) Table 132. Latin America Filgrastim Injection Sales Market Share Forecast by Country (2027-2032) Table 133. Latin America Filgrastim Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Latin America Filgrastim Injection Market Size by Country (2021-2026) & (US$ Million) Table 135. Latin America Filgrastim Injection Market Share by Country (2021-2026) Table 136. Latin America Filgrastim Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Latin America Filgrastim Injection Market Share Forecast by Country (2027-2032) Table 138. Middle East and Africa Filgrastim Injection Market Size Growth Rate (CAGR) by Country (K L): 2021 VS 2025 VS 2032 Table 139. Middle East and Africa Filgrastim Injection Sales by Country (2021-2026) & (K L) Table 140. Middle East and Africa Filgrastim Injection Sales Market Share by Country (2021-2026) Table 141. Middle East and Africa Filgrastim Injection Sales Forecast by Country (2027-2032) & (K L) Table 142. Middle East and Africa Filgrastim Injection Sales Market Share Forecast by Country (2027-2032) Table 143. Middle East and Africa Filgrastim Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East and Africa Filgrastim Injection Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East and Africa Filgrastim Injection Market Share by Country (2021-2026) Table 146. Middle East and Africa Filgrastim Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East and Africa Filgrastim Injection Market Share Forecast by Country (2027-2032) Table 148. Key Raw Materials Table 149. Raw Materials Key Suppliers Table 150. Filgrastim Injection Distributors List Table 151. Filgrastim Injection Customers List Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Filgrastim Injection Image Figure 2. Global Filgrastim Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Filgrastim Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Filgrastim Injection Sales (2021-2032) & (K L) Figure 5. 300mcg/0.5mL (Prefilled Syringe) Image Figure 6. Global 300mcg/0.5mL (Prefilled Syringe) Sales YoY Growth (2021-2032) & (K L) Figure 7. 300mcg/mL (vial) Image Figure 8. Global 300mcg/mL (vial) Sales YoY Growth (2021-2032) & (K L) Figure 9. 480mcg/0.8mL (Prefilled Syringe) Image Figure 10. Global 480mcg/0.8mL (Prefilled Syringe) Sales YoY Growth (2021-2032) & (K L) Figure 11. 480mcg/1.6 mL (vial) Image Figure 12. Global 480mcg/1.6 mL (vial) Sales YoY Growth (2021-2032) & (K L) Figure 13. Global Filgrastim Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Filgrastim Injection Market Share by Type 2025 VS 2032 Figure 15. North America Filgrastim Injection Sales Market Share in Volume by Type in 2025 Figure 16. North America Filgrastim Injection Sales Market Share in Value by Type in 2025 Figure 17. Europe Filgrastim Injection Sales Market Share in Volume by Type in 2025 Figure 18. Europe Filgrastim Injection Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Filgrastim Injection Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Filgrastim Injection Sales Market Share in Value by Type in 2025 Figure 21. Latin America Filgrastim Injection Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Filgrastim Injection Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Filgrastim Injection Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Filgrastim Injection Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Filgrastim Injection Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Adult Use Image Figure 28. Global Adult Use Sales YoY Growth (2021-2032) & (K L) Figure 29. Pediatric Use Image Figure 30. Global Pediatric Use Sales YoY Growth (2021-2032) & (K L) Figure 31. Geriatric Use Image Figure 32. Global Geriatric Use Sales YoY Growth (2021-2032) & (K L) Figure 33. Global Filgrastim Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Filgrastim Injection Market Share by Application 2025 VS 2032 Figure 35. North America Filgrastim Injection Sales Market Share in Volume by Application in 2025 Figure 36. North America Filgrastim Injection Sales Market Share in Value by Application in 2025 Figure 37. Europe Filgrastim Injection Sales Market Share in Volume by Application in 2025 Figure 38. Europe Filgrastim Injection Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Filgrastim Injection Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Filgrastim Injection Sales Market Share in Value by Application in 2025 Figure 41. Latin America Filgrastim Injection Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Filgrastim Injection Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Filgrastim Injection Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Filgrastim Injection Sales Market Share in Value by Application in 2025 Figure 45. North America Filgrastim Injection Sales by Country: 2021 VS 2025 VS 2032 (K L) Figure 46. North America Filgrastim Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Filgrastim Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Filgrastim Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Filgrastim Injection Sales by Country: 2021 VS 2025 VS 2032 (K L) Figure 50. Europe Filgrastim Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Filgrastim Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Filgrastim Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Filgrastim Injection Sales by Country: 2021 VS 2025 VS 2032 (K L) Figure 54. Asia-Pacific Filgrastim Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Filgrastim Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Filgrastim Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Filgrastim Injection Sales by Country: 2021 VS 2025 VS 2032 (K L) Figure 58. Latin America Filgrastim Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Filgrastim Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Filgrastim Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Filgrastim Injection Sales by Country: 2021 VS 2025 VS 2032 (K L) Figure 62. Middle East and Africa Filgrastim Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Filgrastim Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Filgrastim Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Filgrastim Injection Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Filgrastim Injection Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 300mcg/0.5mL (Prefilled Syringe)
  • 300mcg/mL (vial)
  • 480mcg/0.8mL (Prefilled Syringe)
  • 480mcg/1.6 mL (vial)
Applications
  • Adult Use
  • Pediatric Use
  • Geriatric Use
Companies covered
  • Teva Pharmaceuticals
  • Novartis AG
  • Pfizer
  • Amgen Inc
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Filgrastim Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Filgrastim Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Filgrastim Injection Market by Type
  6. 1.3.1 300mcg/0.5mL (Prefilled Syringe)
  7. 1.3.2 300mcg/mL (vial)
  8. 1.3.3 480mcg/0.8mL (Prefilled Syringe)
  9. 1.3.4 480mcg/1.6 mL (vial)
  10. 1.4 Global Filgrastim Injection Market Size by Type
  11. 1.4.1 Global Filgrastim Injection Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Filgrastim Injection Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Filgrastim Injection Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Filgrastim Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Filgrastim Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Filgrastim Injection Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Filgrastim Injection Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Filgrastim Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Filgrastim Injection Industry Trends
  2. 2.2 Filgrastim Injection Industry Drivers
  3. 2.3 Filgrastim Injection Industry Opportunities and Challenges
  4. 2.4 Filgrastim Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Filgrastim Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Filgrastim Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Filgrastim Injection Price (2021-2026)
  4. 3.4 Global Filgrastim Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Filgrastim Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Filgrastim Injection Company, Product Type & Application
  7. 3.7 Global Filgrastim Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Filgrastim Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Filgrastim Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Filgrastim Injection Tier 1, Tier 2, and Tier 3
4 Filgrastim Injection Regional Status and Outlook
  1. 4.1 Global Filgrastim Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Filgrastim Injection Historic Market Size by Region
  3. 4.2.1 Global Filgrastim Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Filgrastim Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Filgrastim Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Filgrastim Injection Forecasted Market Size by Region
  7. 4.3.1 Global Filgrastim Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Filgrastim Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Filgrastim Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Filgrastim Injection by Application
  1. 5.1 Filgrastim Injection Market by Application
  2. 5.1.1 Adult Use
  3. 5.1.2 Pediatric Use
  4. 5.1.3 Geriatric Use
  5. 5.2 Global Filgrastim Injection Market Size by Application
  6. 5.2.1 Global Filgrastim Injection Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Filgrastim Injection Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Filgrastim Injection Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Filgrastim Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Filgrastim Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Filgrastim Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Filgrastim Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Filgrastim Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Pharmaceuticals
  2. 6.1.1 Teva Pharmaceuticals Company Information
  3. 6.1.2 Teva Pharmaceuticals Business Overview
  4. 6.1.3 Teva Pharmaceuticals Filgrastim Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceuticals Filgrastim Injection Product Portfolio
  6. 6.1.5 Teva Pharmaceuticals Recent Developments
  7. 6.2 Novartis AG
  8. 6.2.1 Novartis AG Company Information
  9. 6.2.2 Novartis AG Business Overview
  10. 6.2.3 Novartis AG Filgrastim Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novartis AG Filgrastim Injection Product Portfolio
  12. 6.2.5 Novartis AG Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Filgrastim Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Filgrastim Injection Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 Amgen Inc
  20. 6.4.1 Amgen Inc Company Information
  21. 6.4.2 Amgen Inc Business Overview
  22. 6.4.3 Amgen Inc Filgrastim Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Amgen Inc Filgrastim Injection Product Portfolio
  24. 6.4.5 Amgen Inc Recent Developments
  25. 6.5 Accord Healthcare
  26. 6.5.1 Accord Healthcare Company Information
  27. 6.5.2 Accord Healthcare Business Overview
  28. 6.5.3 Accord Healthcare Filgrastim Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Accord Healthcare Filgrastim Injection Product Portfolio
  30. 6.5.5 Accord Healthcare Recent Developments
7 North America by Country
  1. 7.1 North America Filgrastim Injection Sales by Country
  2. 7.1.1 North America Filgrastim Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Filgrastim Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Filgrastim Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Filgrastim Injection Market Size by Country
  6. 7.2.1 North America Filgrastim Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Filgrastim Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Filgrastim Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Filgrastim Injection Sales by Country
  2. 8.1.1 Europe Filgrastim Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Filgrastim Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Filgrastim Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Filgrastim Injection Market Size by Country
  6. 8.2.1 Europe Filgrastim Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Filgrastim Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Filgrastim Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Filgrastim Injection Sales by Country
  2. 9.1.1 Asia-Pacific Filgrastim Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Filgrastim Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Filgrastim Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Filgrastim Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Filgrastim Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Filgrastim Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Filgrastim Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Filgrastim Injection Sales by Country
  2. 10.1.1 South America Filgrastim Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Filgrastim Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Filgrastim Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Filgrastim Injection Market Size by Country
  6. 10.2.1 South America Filgrastim Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Filgrastim Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Filgrastim Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Filgrastim Injection Sales by Country
  2. 11.1.1 Middle East and Africa Filgrastim Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Filgrastim Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Filgrastim Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Filgrastim Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Filgrastim Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Filgrastim Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Filgrastim Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Filgrastim Injection Value Chain Analysis
  2. 12.1.1 Filgrastim Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Filgrastim Injection Production Mode & Process
  7. 12.2 Filgrastim Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Filgrastim Injection Distributors
  10. 12.2.3 Filgrastim Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst